Synthesis and cytotoxicity of the 4-(1-benzyl-1H-indazol-3-yl)-N-hydroxybenzamide analogs?

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 藥學院 > 藥物化學研究所 > 會議論文 > Item 310903500/22745

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/22745

题名:	Synthesis and cytotoxicity of the 4-(1-benzyl-1H-indazol-3-yl)-N-hydroxybenzamide analogs?
作者:	(Hua-Sin Chen(陳華);(Chiung-Wen Kuo);黃敬哲(Jing-Je Huang);(You-Sin Chang);(Chun-Ta Feng);郭盛助(Sheng-Chu Kuo);黃麗嬌(Li-Jiau Huang)?
贡献者:	藥學院藥物化學研究所;?
日期:	2005-09-4?
上传时间:	2009-09-07 12:18:27 (UTC+8)
摘要:	Ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) was first synthesized in our laboratory as a novel anti-angiogenic agent. Recently, a series of YD-3 derivatives were synthesized, and these compounds were assayed for their cytotoxicity against HL-60 human leukemia cells. Among them, compound 4-(1-benzyl-1H-indazol-3-yl)-N-hydroxybenzamide (I) (IC50 = 2.5 mM) exhibited significant cytotoxicity against HL-60 human leukemia cells, which was superior to YD-3 (IC50 = 50.0 mM). Encouraged by this initial result, compound I was used as a lead compound, and a series of its analogs were synthesized and evaluated for their cytotoxicity of human hepatoma cell line (Hep 3B), human lung carcinoma cell line (A549), human colorectal adenocarcinoma cell line (COLO 205), human cervix adenocarcinoma cell line (HeLa), and human leukemia cell line (HL-60).?
關聯:	2005藥物化學研討會?
显示于类别:	[藥物化學研究所] 會議論文

文件中的档案:

没有与此文件相关的档案.

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章